Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1100 of 6351
-
Can surgery offer lasting relief for chronic heartburn? a large registry investigates
Disease control CompletedProspective registry comparing outcomes after laparoscopic treatment of gastroesophageal reflux disease and hiatal hernia.
Sponsor: The Heartburn Foundation • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Experimental combo aims to reboot immune system against Hard-to-Treat cancers
Disease control Recruiting nowThe purpose of this study is to assess the feasibility, safety, and efficacy of anti-PD-1 antibody alone or in combination with low-dose decitabine in patients with relapsed or refractory malignancies, including Non-Hodgkin'lymphoma, Hodgkin'lymphoma, gastrointestinal cancers, he…
Phase 1/2 • Sponsor: Han weidong • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Immunotherapy plus chemo shows promise for bladder cancer before surgery
Disease control CompletedThe purpose of this study is to evaluate whether adding pembrolizumab (Keytruda) to the combination of gemcitabine and cisplatin will improve shrinkage of the tumor before having a cystectomy, for people with muscle-invasive bladder cancer (MIBC).
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Stem cell transplant shows promise against rare blood cancer
Disease control CompletedThe purpose of this study is to evaluate whether autologous stem cell transplantation will improve the survival of patients with high-risk Waldenström macroglobulinemia, compared with conventional chemotherapy.
Phase 4 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New combo attack on recurrent brain tumors shows promise in early trial
Disease control Recruiting nowPrimary brain tumors are typically treated by surgery, radiation therapy and chemotherapy, either individually or in combination. Present therapies are inadequate, as evidenced by the low 5-year survival rate for brain cancer patients, with median survival at approximately 12 mon…
Phase 2 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Nurse Check-Ins after suicide attempt show promise in preventing repeat crisis
Prevention CompletedTo evaluate the impact of a specific nursing management (personalized and close, through consultation at the hospital, at home or by phone) monitoring in post-hospitalization, the suicide attempt of recurrence and suicidal crisis, in the year following a suicide attempt in patien…
Sponsor: University Hospital, Montpellier • Aim: Prevention
Last updated Jun 27, 2026 13:01 UTC
-
Breath analysis may sniff out lung cancer
Diagnosis CompletedTo answer the question whether a disease specific profile of breath in patients with lung cancer can be detected by an untargeted metabolomic study using exhaled breath analysis by mass spectrometry.
Sponsor: University of Zurich • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
Which radiation approach spares prostate cancer Patients' bladder function?
Disease control OngoingThis study will offer men with intermediate risk prostate cancer who are suitable for, and interested in, prostate brachytherapy, the opportunity to be randomized between low dose rate (LDR) brachytherapy using permanent implantation of radioactive seeds (the current standard of …
Phase 3 • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a hidden artery condition explain heart attacks in young women?
Knowledge-focused CompletedSpontaneous Coronary Artery Dissection (SCAD) is a rare and often misdiagnosed cause of Acute Coronary Syndrome (ACS) affecting predominantly young women without cardiovascular risk factors. The origin of SCAD remains uncertain but a strong and frequent association with Fibromusc…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
New drug cocktail aims to keep myeloma at bay after transplant
Disease control OngoingThis is a Phase 3 randomized trial of carfilzomib, lenalidomide, dexamethasone versus lenalidomide alone after stem-cell transplant for multiple myeloma, eligible to subjects who completed autologous stem cell transplant for symptomatic myeloma who are considered for lenalidomide…
Phase 3 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Could cleaning the gums protect a transplanted heart?
Disease control CompletedHeart transplant recipients frequently exhibit chronic low-grade systemic inflammation, which can contribute to allograft dysfunction and cardiovascular complications. Periodontitis, a chronic inflammatory disease of the tooth-supporting tissues, is a modifiable but often overloo…
Sponsor: Baskent University • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Could a Pacemaker-Like device ease heart failure?
Disease control CompletedThe purpose of this clinical trial (NCT02627196) is to develop valid scientific evidence for safety and effectiveness of Baroreflex Activation Therapy with the BAROSTIM NEO System in subjects with heart failure, defined as New York Heart Association (NYHA) functional Class III, l…
Sponsor: CVRx, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Gene-Tailored therapy shows promise for aggressive breast cancer
Knowledge-focused OngoingBreast cancer is an optimal "model disease" for studying personalized medicine. Breast cancer was the first malignancy for which a predictive factor forecasting response to therapy was identified nearly 50 years ago; the expression of the estrogen receptor (ER). Furthermore, brea…
Phase 2 • Sponsor: Haukeland University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Can a daily aspirin help fight colorectal cancer? new trial targets genetic weakness
Disease control OngoingALASCCA is a randomized, parallel group, double blind, multicenter, placebo-controlled, biomarker-based study of adjuvant treatment with low dose aspirin in patients with colorectal cancer. Hypothesis is that patients diagnosed with colorectal cancer and somatic mutations in PI3K…
Phase 3 • Sponsor: Anna Martling • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New triple inhaler shows promise for uncontrolled asthma
Disease control CompletedEvaluate the superiority of CHF 5993 200/6/12.5 µg pressurised metered dose inhaler (pMDI) (fixed combination of extrafine beclometasone dipropionate plus formoterol fumarate plus glycopyrronium bromide) versus CHF 1535 200/6 µg pMDI (fixed combination of extrafine beclometasone …
Phase 3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New study tests if proton therapy spares hearts in breast cancer patients
Disease control OngoingA pragmatic randomized clinical trial of patients with locally advanced breast cancer randomized to either proton or photon therapy and followed longitudinally for cardiovascular morbidity and mortality, health-related quality of life, and cancer control outcomes. Quality of life…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Lifestyle makeover: can diet and exercise curb cancer risk?
Prevention OngoingThis randomized pilot research trial studies how well Eat, Move, Live (EML) works in reducing chronic disease risk in medically vulnerable communities. Obesity, unhealthy diet, and physical inactivity are linked to increased cancer risk, especially hormone-related cancer (example…
Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
Lung cancer drug cocktail shows promise in delaying tumor growth
Disease control CompletedThis is a randomized, open-label, controlled, multicenter, Phase III study. Patients will be randomly assigned to treatment group (1:1) through a dynamic randomization process with use of the following stratification factors: sex (female/male), disease stage (stage IIIb vs. stage…
Phase 3 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New proton beam combo aims to shrink pancreatic tumors for surgery
Disease control Recruiting nowThe prognosis for patients with localized pancreatic adenocarcinoma who are not surgical candidates is poor. Patients characterized as having "borderline resectable" disease treated with preoperative chemo-radiotherapy fair somewhat better - although many of these patients are no…
Phase 2 • Sponsor: Proton Collaborative Group • Aim: Disease control
Last updated Jun 26, 2026 14:24 UTC
-
Gene therapy shot aimed at diabetic nerve pain put to the test
Symptom relief CompletedThe purpose of this study is to determine the safety and efficacy of bilateral intramuscular injections of VM202 versus placebo in the treatment of painful diabetic peripheral neuropathy. A total of 507 of 477 planned participants were randomized in a 2:1 ratio to one of two tre…
Phase 3 • Sponsor: Helixmith Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC